Microvascular Obstruction: The Bane of Myocardial Reperfusion

Affiliations

¹ The Hatter Cardiovascular Institute, University College London, London, United Kingdom; The National Institute of Health Biomedical Research Centre, University College London Hospitals, London, United Kingdom.
² The Hatter Cardiovascular Institute, University College London, London, United Kingdom; The National Institute of Health Biomedical Research Centre, University College London Hospitals, London, United Kingdom; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, Singapore. Electronic address: derek.hausenloy@duke-nus.edu.sg.

Editorial

Heerajnarain Bulluck et al. Rev Esp Cardiol (Engl Ed). 2015 Nov.

. 2015 Nov;68(11):919-20.

doi: 10.1016/j.rec.2015.06.022.

¹ The Hatter Cardiovascular Institute, University College London, London, United Kingdom; The National Institute of Health Biomedical Research Centre, University College London Hospitals, London, United Kingdom.
² The Hatter Cardiovascular Institute, University College London, London, United Kingdom; The National Institute of Health Biomedical Research Centre, University College London Hospitals, London, United Kingdom; National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore; Cardiovascular and Metabolic Disorders Program, Duke-National University of Singapore, Singapore. Electronic address: derek.hausenloy@duke-nus.edu.sg.

No abstract available

Comment on

Intracoronary Infusion of Thioflavin-S to Study Microvascular Obstruction in a Model of Myocardial Infarction.
Hervas A, de Dios E, Forteza MJ, Miñana G, Nuñez J, Ruiz-Sauri A, Bonanad C, Perez-Sole N, Chorro FJ, Bodi V. Hervas A, et al. Rev Esp Cardiol (Engl Ed). 2015 Nov;68(11):928-34. doi: 10.1016/j.rec.2015.04.016. Epub 2015 Aug 5. Rev Esp Cardiol (Engl Ed). 2015. PMID: 26253860